go back

Idecabtagene Vicleucel (Abecma), up to 460 Million Cells

New Jersey rates for HCPCS C9081

Idecabtagene vicleucel, up to 460 million autologous anti-BCMA CAR-positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Rates data updated July 2026.

Facilitymedian $13,804 · 10th–90th $135$30,2000%10%10th90th$13,804Professionalmedian $426,580 · 10th–90th $426,580$426,5800%50%$426,580$100.0$500.0$2.0K$10.0K$50.0K$200.0K$1.0M

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Horizon BCBS
Setting
Facility
Modifier
Global
Typical Low
$134.90
Median
$13,803.84
Typical High
$30,199.52
Horizon BCBS
Setting
Professional
Modifier
Global
Typical Low
$426,579.52
Median
$426,579.52
Typical High
$426,579.52
United
Setting
Professional
Modifier
Global
Typical Low
$549,540.87
Median
$549,540.87
Typical High
$549,540.87